Skip to content

Effect of early high frequency ventilation on death in children with acute lung disease

Early vs Conventional High-Frequency Oscillatory Ventilation in Moderate and Severe Acute Respiratory Distress syndrome: An Open Labelled Randomized Superiority Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094156
Enrollment
50
Registered
2025-09-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J960- Acute respiratory failure

Interventions

Intervention1: Early high frequency oscillatory ventilation, a modality of invasive ventilation: Children diagnosed with moderate or severe acute respiratory distress syndrome are upfront initiated on

Sponsors

Division of Pediatric Critical Care Department of Pediatrics AIIMS Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 1 month to 14 years admitted in PICU, with moderate and severe ARDS classified as per PALICC 1 guidelines.

Exclusion criteria

Exclusion criteria: 1. History of interstitial lung disease 2. Chronic renal failure 3. Central nervous system involvement: Especially raised intracranial pressure 4. Immunodeficient patients including malignancy and post marrow transplant recipients 5. Post cardiac surgery patients 6. Consent denial

Design outcomes

Primary

MeasureTime frame
To compare 28-day mortality outcomes between early HFOV group and conventional/ rescue HFOV group.Timepoint: To compare 28-day mortality outcomes between early HFOV group and conventional/ rescue HFOV group.

Secondary

MeasureTime frame
To determine the time taken for improvement in oxygenation and ventilatory parameters, duration of ventilation and length of ICU stay.Timepoint: Till patient is in ICU

Countries

India

Contacts

Public ContactSathwik Gangireddy

All India Institute of Medical Sciences, Raipur

drmrsahoo@gmail.com9786722877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026